From Research to Application: Projects at Fraunhofer EMFT

The SmartMan project aims to make semiconductor packaging production intelligent and sustainable in order to manufacture error-free and resource-efficient electronics.

SENNA is a programmable neuromorphic processor based on a mixed-signal, circuit‑switched Field‑Programmable Spiking Neuron Array (FPSNA).

By 2030, global semiconductor production is expected to be almost twice as high as it is today. To mitigate the negative environmental impact, 58 European partners in the EU GENESIS project have set themselves the goal of developing more environmentally friendly materials and processes in the semiconductor industry. As part of the project, Fraunhofer EMFT researchers are working on optimizing exhaust gas purification methods and increasing the efficiency and environmental sustainability of production processes.

In the QuQuSemi project, a Fraunhofer EMFT research team is working together with Quantum Diamonds and the Technical University of Munich on a high-resolution microscope based on diamond-based quantum sensors that is specially designed for analyzing semiconductor components. With a spatial resolution of just 100 nanometers at room temperature, it aims to enable the precise measurement of the smallest magnetic fields and temperature differences.

3D tissue models offer a drug development alternative to animal testing, enabling precise cell activity monitoring beyond optical limits.

At the core of the partnership between Fraunhofer EMFT and Daiken Medical is the development and successful licensing of the world's smallest micromembrane pump. This technology revolutionizes microdosing and opens up new application possibilities in pain therapy. An important step was the technology transfer of the patented micromembrane pump to Daiken Medical in Osaka, which is now developing the PCA system "Amy," allowing patients to independently manage their pain treatment.

Unlooc is a project that focuses on the development of organ-on-a-chip (OOC) technologies. These technologies aim to improve the efficiency of drug testing while reducing the need for animal testing. The Fraunhofer EMFT research team is supporting the development of the organ-on-chip multiwell plates, which offer precise control of cell culture conditions and enable animal-free pharmaceutical testing.

Every year, over 3 million immobile people worldwide suffer from severe, mostly preventable pressure ulcers, with around 0.6 million in Germany. Pressure ulcers not only cause personal suffering but are also time-consuming and costly to treat. Current prophylaxis methods require significant commitment from nursing staff and do not provide continuous security. Therefore, there is an urgent need for individual and continuous monitoring for effective pressure ulcer prophylaxis. SoreAlert, a potential spin-off from Fraunhofer EMFT, addresses this need with a smart patch that allows for automated monitoring of at-risk body areas and provides early warnings for pressure ulcers.

The DigiSeal research project is setting new standards in the predictive maintenance of mechanical seals, which are essential for many branches of industry. By using informed AI and the expertise of Fraunhofer EMFT, precise models are being developed that not only predict maintenance requirements, but also provide specific recommendations for action. Together with partners such as EagleBurgmann Germany GmbH & Co. KG, Molkerei Alois Müller GmbH & Co. KG and Munich University of Applied Sciences, digitalization in the industry is being driven forward and a significant contribution is being made to Industry 4.0.

We all know it: wintertime is cold season and cough or headache tablets are often part of everyday life. But our gastrointestinal tract absorbs medication differently. In the “e-Pille” project, scientists from the Fraunhofer Institutes ITMP, EMFT and IZM are researching the points in the gastrointestinal tract where different active ingredients are best absorbed. The aim is to optimize the formulation of new drugs when taken orally.